AbCellera Biologics (ABCL) EPS (Basic) (2020 - 2023)
Historic EPS (Basic) for AbCellera Biologics (ABCL) over the last 4 years, with Q4 2023 value amounting to -$0.17.
- AbCellera Biologics' EPS (Basic) fell 7000.0% to -$0.17 in Q4 2023 from the same period last year, while for Dec 2023 it was -$0.52, marking a year-over-year decrease of 19285.71%. This contributed to the annual value of -$0.55 for FY2024, which is 784.31% down from last year.
- Latest data reveals that AbCellera Biologics reported EPS (Basic) of -$0.17 as of Q4 2023, which was down 7000.0% from -$0.1 recorded in Q3 2023.
- In the past 5 years, AbCellera Biologics' EPS (Basic) registered a high of $0.59 during Q1 2022, and its lowest value of -$0.17 during Q4 2023.
- Over the past 4 years, AbCellera Biologics' median EPS (Basic) value was -$0.02 (recorded in 2020), while the average stood at $0.07.
- As far as peak fluctuations go, AbCellera Biologics' EPS (Basic) soared by 440000.0% in 2021, and later crashed by 42833.87% in 2023.
- Quarter analysis of 4 years shows AbCellera Biologics' EPS (Basic) stood at $0.52 in 2020, then tumbled by 57.69% to $0.22 in 2021, then crashed by 145.45% to -$0.1 in 2022, then crashed by 70.0% to -$0.17 in 2023.
- Its last three reported values are -$0.17 in Q4 2023, -$0.1 for Q3 2023, and -$0.11 during Q2 2023.